[HTML][HTML] P‐and E‐selectin in venous thrombosis and non‐venous pathologies
M Purdy, A Obi, D Myers, T Wakefield - Journal of Thrombosis and …, 2022 - Elsevier
Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
[HTML][HTML] P‐and E‐selectin in venous thrombosis and non‐venous pathologies
M Purdy, A Obi, D Myers, T Wakefield - Journal of Thrombosis and …, 2022 - ncbi.nlm.nih.gov
Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
P‐and E‐selectin in venous thrombosis and non‐venous pathologies
M Purdy, A Obi, D Myers… - Journal of Thrombosis and …, 2022 - Wiley Online Library
Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
P-and E-selectin in venous thrombosis and non-venous pathologies
M Purdy, A Obi, D Myers… - Journal of thrombosis …, 2022 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
P-and E-selectin in venous thrombosis and non-venous pathologies.
M Purdy, A Obi, D Myers, T Wakefield - Journal of Thrombosis and …, 2022 - europepmc.org
Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
[HTML][HTML] P‐and E‐selectin in venous thrombosis and non‐venous pathologies
M Purdy, A Obi, D Myers, T Wakefield - Journal of Thrombosis and …, 2022 - jthjournal.org
Venous thromboembolism is a very common and costly health problem worldwide.
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …
Anticoagulant treatment for VTE is imperfect: all have the potential for significant bleeding …